Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 5, 2004, Pages 310-319

  Hallemeier, C ^a   Girgis, M ^a   Blum, W ^a   Brown, R ^a   Khoury, H ^a   Goodnough, L T ^a   Vij, R ^a   Devine, S ^a   Wehde, M ^a   Postma, S ^a   Lin, H S ^a   Dipersio, J ^a   Adkins, Douglas ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute myelogenous leukemia; Reduced intensity conditioning; Total body irradiation; Unrelated donor transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; CEFEPIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; ITRACONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RIFAMPICIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BACTERIAL INFECTION; BLADDER DISEASE; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; BRONCHITIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; DRUG FATALITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HUMAN; INTERSTITIAL PNEUMONIA; KAPLAN MEIER METHOD; LENGTH OF STAY; LIVER VENOOCCLUSIVE DISEASE; MALE; MOUTH DISEASE; MYCOSIS; NEUROLOGIC DISEASE; RADIATION DOSE; RADIATION EXPOSURE; RISK ASSESSMENT; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RADIATION DOSAGE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 11144356500     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2003.12.002     Document Type: Article

References (40)

1. NMDP Overview 2001 National Marrow Donor Program
2. Szydlo R. Goldman J.M. Klein J.P. et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 15 1997 1767-1777
3. McGlave P.B. Shu X.-O. Wen W. et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program Blood 95 2000 2219-2225
4. Storb R. Raff R.F. Graham T. et al. Marrow toxicity of fractionated vs single dose total body irradiation is identical in a canine model Int J Radiat Oncol Biol Phys 26 1993 275-283
5. Storb R. Raff R.F. Appelbaum F.R. et al. What radiation dose for DLA-identical canine marrow grafts? Blood 72 1998 1300-1304
6. Storb R. Raff R.F. Appelbaum F.R. et al. Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts Blood 74 1989 1139-1143
7. Storb R. Raff R.F. Applebaum F.R. et al. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts Blood 83 1994 3384-3389
8. Fyles G.M. Messner H.A. Lockwood G. et al. Long-term results of bone marrow transplantation for patients with AML, ALL, and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate Bone Marrow Transplant 8 1991 453-463
9. Blum W. Brown R. Lin H.-S. et al. Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity Biol Blood Marrow Transplant 11 2002 608-618
10. Bensinger W.I. Martin P.J. Storer B. et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA identical relatives in patients with hematologic cancers N Engl J Med 344 2001 175-181
11. Girgis M. Brown R. Khoury H. et al. Low dose (550 cGy), single exposure total body irradiation and cyclophosphamide as conditioning for unrelated donor bone marrow transplant results in consistent donor cell engraftment without fatal regimen-related toxicity Blood 98 2001 478a-479a (abstr.)
12. Girgis M. Hallemeier C. Brown R. et al. Low dose (550 cGy), single exposure total body irradiation and cyclophosphamide as conditioning for unrelated donor bone marrow transplantation results in reduced non-relapse mortality in comparison to standard TBI-based regimens Blood 98 2001 671a (abstr.)
13. Davies S. Kollman C. Anasetti C. et al. Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the National Marrow Donor Program Blood 96 2000 4096-4102
14. NIH Transplantation Immunology Branch Staff Lymphocytotoxicity. In: Ray J.G. Hare D.B. Pederson P.D. et al. (Eds.), NIAID Manual of Tissue Typing Techniques (DHEW Publication No. 76-545) 1976 22 National Institutes of Health, National Institute of Allergy and Infectious Diseases, Research Resources BranchBethesda, MD
15. Duffy B.F. Begovich A.B. Novotny J.F. Mohanakumar T. Allele level HLA DRB typing with Amplicor (RELI™) typing kit using extended panel of primers and probes Hum Immunol 55 1997 137 (abstr.)
16. Glucksberg H. Storb R. Refer A. et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 18 1997 295-304
17. Shulman H. Sullivan K. Weiden P. et al. Chronic graft-versus-host syndrome in man Am J Med 69 1980 204-217
18. Reed K.C. Mann D.A. Rapid transfer of DNA from agarose gels to nylon membranes Nucleic Acids Res 13 1985 7202-7221
19. Wong Z. Wilson V. Patel I. Povey S. Jeffreys A.J. Characterization of a panel of highly variable minisatellites cloned from human DNA Ann Hum Genet 51 1987 269-288
20. Kaplan E.L. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457-481
21. NCI Common Toxicity Criteria, Version 2.0 1998 National Institutes of Health, National Cancer InstituteWashington, DC
22. Byrd J. Mrózek K. Dodge R.K. et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) Blood 100 2002 4325-4336
23. Raimondi S.C. Chang M.N. Ravindranath Y. et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study-POG 8821 Blood 94 1999 3707-3716
24. Sierra J. Storer B. Hansen J.A. et al. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience Bone Marrow Transplant 26 2000 397-404
25. Zittoun R.A. Mandelli F. Willemze R. et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia N Engl J Med 334 1995 217-223
26. Kernan N. Bartsch G. Ash R.C. et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program N Engl J Med 328 1993 593-602
27. Joachim Deeg H. Seidel K. Casper J. et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy Biol Blood Marrow Transplant 5 1999 243-252
28. Castro-Malaspina H. Harris R.E. Gajewski J. et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated be the National Marrow Donor Program Blood 99 2002 1943-1951
29. Clift R.A. Buckner C.D. Appelbaum F.R. et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens Blood 76 1990 1867-1871
30. Childs R. Clave E. Contentin N. et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses Blood 94 1999 3234-3241
31. Clift R.A. Buckner C.D. Appelbaum F.R. et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens Blood 77 1991 1660-1665
32. Blume K.G. Kopecky K.J. Henslee J.P. et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study Blood 81 1993 2187-2193
33. Giralt S.A. LeMaistre C.F. Vriesendorp H.M. et al. Etoposide, cyclophosphamide, total body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies J Clin Oncol 12 1994 1923-1930
34. Niederwieser D. Maris M. Shizuru J.A. et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Blood 101 2003 1620-1629
35. Childs R. Clave E. Contentin N. et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses Blood 94 1999 3234-3241
36. Childs R. Chernoff A. Contentin N. et al. Regression of metastatic renal cell carcinoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation N Engl J Med 343 2000 750-758
37. Spizer T.R. McAfee S. Sackstein R. et al. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies Biol Blood Marrow Transplant 6 2000 309-320
38. Hill G.R. Ferrara J.L.M. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for use of cytokine shields in allogeneic bone marrow transplantation Blood 95 2000 2754-2759
39. Hill G.R. Crawford J.M. Cooke K.R. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines Blood 90 1997 3204-3213
40. Girgis M. Hallemeier C. Blum W. et al. Low-dose (550cGy), single exposure total body irradiation with cyclophosphamide as conditioning for 99 patients undergoing unrelated donor bone marrow transplantation results in a graft failure rate (7.1%) comparable to that observed with standard TBI-based regimens Blood 100 2002 619a (abstr.)